lithium not effective in ALS

Despite promising results from an Italian pilot study, follow-up trials of lithium in ALS have failed to show any benefits for the drug

posted on April 12, 2010 - 8:15pm

An MDA-supported, 10-center trial of more than 100 people with amyotrophic lateral sclerosis (ALS) who took the oral medication lithium carbonate — some in conjunction with the ALS drug riluzole — has shown the drug does not provide benefit for disease progression or survival.
The study also showed that lithium can have concerning side effects, and when taken alone (without riluzole),...